|
Market Closed -
NYSE
21:00:03 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 181.55 USD | +0.12% |
|
-1.33% | +59.80% |
| 08-25 | Davita Inc. Announces New Value-Based Partnership with Humana Inc. to Expand Care for Patients with Chronic Kidney Disease | CI |
| 08-25 | DaVita Reaches Kidney Care Agreement With Humana | MT |
| Market Cap | 11.58B 9.98B 9.45B 8.56B 16.06B 1,106B 16.14B 112B 43.14B 563B 43.48B 42.53B 1,778B | P/E 2026 * |
12.5x | P/E 2027 * | 10.6x |
|---|---|---|---|---|---|
| Enterprise Value | 22.4B 19.3B 18.28B 16.57B 31.08B 2,140B 31.23B 217B 83.47B 1,089B 84.13B 82.29B 3,441B | EV / Sales 2026 * |
1.58x | EV / Sales 2027 * | 1.53x |
| Free-Float |
49.06% | Yield 2026 * |
0.92% | Yield 2027 * | 0.92% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| DVA | Delayed | |
CBOE
| DVA | Real-time | |
|
London S.E.
| 0I7E | Delayed | |
|
Mexican S.E.
| DVA * | End-of-day quote | |
|
Borsa Italiana
| 1DVA | End-of-day quote | |
|
Deutsche Boerse AG
| TRL | Delayed | |
|
Tradegate
| TRL | Real-time | |
|
Börse Stuttgart
| TRL | Delayed | |
|
Boerse Muenchen
| TRL | Real-time | |
|
Berne S.E.
| TRL | End-of-day quote | |
|
Xetra
| TRL | Delayed |
Last Transcript : DaVita Inc.
| 1 day | +0.12% | ||
| 1 week | -1.33% | ||
| Current month | +3.15% | ||
| 1 month | +0.03% | ||
| 3 months | -12.99% | ||
| 6 months | +18.61% | ||
| Current year | +59.80% |
| 1 week | 176.82 |  | 185.26 |
| 1 month | 171.4 | | 185.26 |
| Current year | 101 | | 247.49 |
| 1 year | 101 | | 247.49 |
| 3 years | 71.51 | | 247.49 |
| 5 years | 65.28 | | 247.49 |
| 10 years | 43.4 | | 247.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Javier Rodriguez
CEO | Chief Executive Officer | 65 | 31/05/2019 |
Joel Ackerman
DFI | Director of Finance/CFO | 61 | 26/02/2017 |
David Maughan
COO | Chief Operating Officer | 49 | 14/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Pamela Arway
CHM | Chairman | 72 | 31/05/2020 |
Barbara Desoer
BRD | Director/Board Member | 73 | 07/10/2015 |
Javier Rodriguez
BRD | Director/Board Member | 65 | 31/05/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/08/26 | Free | Director | 278 | 0.0004% | ||
| 15/08/26 | Free | Chairman | 278 | 0.0004% | ||
| 15/08/26 | Free | Director | 278 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -1.33% | +36.33% | +86.86% | 11.58B | |
| -0.66% | -2.15% | +26.25% | +34.23% | 121B | |
| +1.36% | +5.42% | +5.38% | +63.66% | 92.43B | |
| +0.75% | +3.23% | -3.22% | +57.59% | 29.44B | |
| +1.68% | -0.89% | +28.49% | +84.72% | 25.94B | |
| -0.82% | -0.69% | -2.12% | -1.87% | 21.69B | |
| +0.09% | -0.51% | +36.75% | +273.18% | 21.23B | |
| -1.18% | +1.29% | -4.11% | +29.33% | 16.07B | |
| -0.13% | -1.99% | -9.55% | -4.52% | 11.82B | |
| +20.00% | +17.29% | +73.33% | +2,337.50% | 10.85B | |
| Average | +2.12% | +2.31% | +18.75% | +296.07% | 36.21B | |
| Weighted average by Cap. | +0.81% | +1.46% | +16.82% | +128.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.16B 12.2B 11.55B 10.47B 19.64B 1,353B 19.74B 137B 52.75B 688B 53.17B 52B 2,174B | 14.6B 12.58B 11.91B 10.8B 20.26B 1,395B 20.36B 142B 54.42B 710B 54.85B 53.65B 2,243B |
| Net income | 933M 804M 761M 690M 1.29B 89.13B 1.3B 9.04B 3.48B 45.35B 3.5B 3.43B 143B | 1.02B 875M 828M 751M 1.41B 97.02B 1.42B 9.84B 3.78B 49.36B 3.81B 3.73B 156B |
| Net Debt | 10.82B 9.33B 8.83B 8B 15.02B 1,034B 15.09B 105B 40.33B 526B 40.65B 39.76B 1,662B | 10.8B 9.31B 8.81B 7.99B 14.98B 1,032B 15.06B 105B 40.25B 525B 40.57B 39.68B 1,659B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | US$181.55 | +0.12% | 767,846 |
| 10/09/26 | US$181.33 | -0.92% | 565,297 |
| 09/09/26 | US$183.01 | +1.64% | 688,776 |
| 08/09/26 | US$180.06 | -2.14% | 621,336 |
| 04/09/26 | US$183.99 | +1.28% | 473,725 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DVA Stock
Select your edition
All financial news and data tailored to specific country editions
